Select Publications
Journal articles
2013, 'ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation', Cell Stem Cell, 12, pp. 761 - 773, http://dx.doi.org/10.1016/j.stem.2013.04.006
,2013, 'From functional genomics to precision medicine: The therapeutic potential of targeting ROCK signaling in pancreatic cancer.', Journal of Clinical Oncology, 31, pp. e15029 - e15029, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e15029
,2013, 'Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion', Oncogene, 32, pp. 1252 - 1265, http://dx.doi.org/10.1038/onc.2012.148
,2013, 'Loss of scar/WAVE complex promotes N-WASP- and FAK-dependent invasion', Current Biology, 23, pp. 107 - 117, http://dx.doi.org/10.1016/j.cub.2012.11.059
,2012, 'Scar/WAVE3 contributes to motility and plasticity of lamellipodial dynamics but not invasion in three dimensions', Biochemical Journal, 448, pp. 35 - 42, http://dx.doi.org/10.1042/BJ20112206
,2012, 'N-WASP coordinates the delivery and F-actin-mediated capture of MT1-MMP at invasive pseudopods', Journal of Cell Biology, 199, pp. 527 - 544, http://dx.doi.org/10.1083/jcb.201203025
,2012, 'Inhibition of autophagy impairs tumor cell invasion in an organotypic model', Cell Cycle, 11, pp. 2022 - 2029, http://dx.doi.org/10.4161/cc.20424
,2012, 'Mtss1 regulates epidermal growth factor signaling in head and neck squamous carcinoma cells', Oncogene, 31, pp. 1781 - 1793, http://dx.doi.org/10.1038/onc.2011.376
,2012, 'Rab25 and CLIC3 Collaborate to Promote Integrin Recycling from Late Endosomes/Lysosomes and Drive Cancer Progression', Developmental Cell, 22, pp. 131 - 145, http://dx.doi.org/10.1016/j.devcel.2011.11.008
,2011, 'P-Rex1 is required for efficient melanoblast migration and melanoma metastasis', Nature Communications, 2, http://dx.doi.org/10.1038/ncomms1560
,2011, 'Organotypic collagen I assay: a malleable platform to assess cell behaviour in a 3-dimensional context.', Journal of visualized experiments : JoVE
,2011, 'Organotypic Collagen I Assay: A Malleable Platform to Assess Cell Behaviour in a 3-Dimensional Context', Journal of Visualized Experiments, http://dx.doi.org/10.3791/3089-v
,2011, 'Imaging molecular dynamics in vivo - from cell biology to animal models', Journal of Cell Science, 124, pp. 2877 - 2890, http://dx.doi.org/10.1242/jcs.085191
,2011, 'Live cell in vitro and in vivo imaging applications: Accelerating drug discovery', Pharmaceutics, 3, pp. 141 - 170, http://dx.doi.org/10.3390/pharmaceutics3020141
,2011, 'Spatial regulation of RhoA activity during pancreatic cancer cell invasion driven by mutant p53', Cancer Research, 71, pp. 747 - 757, http://dx.doi.org/10.1158/0008-5472.CAN-10-2267
,2011, 'Actomyosin-mediated cellular tension drives increased tissue stiffness and β-catenin activation to induce epidermal hyperplasia and tumor growth', Cancer Cell, 19, pp. 776 - 791, http://dx.doi.org/10.1016/j.ccr.2011.05.008
,2011, 'FLIM-FRET imaging in vivo reveals 3D-environment spatially regulates RhoGTPase activity during cancer cell invasion', Small Gtpases, 2, pp. 239 - 244, http://dx.doi.org/10.4161/sgtp.2.4.17275
,2010, 'Quantitative in vivo imaging of the effects of inhibiting integrin signaling via Src and FAK on cancer cell movement: Effects on e-cadherin dynamics', Cancer Research, 70, pp. 9413 - 9422, http://dx.doi.org/10.1158/0008-5472.CAN-10-1454
,2010, 'Dasatinib Inhibits the Development of Metastases in a Mouse Model of Pancreatic Ductal Adenocarcinoma', Gastroenterology, 139, pp. 292 - 303, http://dx.doi.org/10.1053/j.gastro.2010.03.034
,2010, 'Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer', Proceedings of the National Academy of Sciences of the United States of America, 107, pp. 246 - 251, http://dx.doi.org/10.1073/pnas.0908428107
,2009, 'Quantitative real-time imaging of molecular dynamics during cancer cell invasion and metastasis in vivo.', Cell adhesion & migration, 3, pp. 351 - 354
,2009, 'Real-time study of E-cadherin and membrane dynamics in living animals: Implications for disease modeling and drug development', Cancer Research, 69, pp. 2714 - 2719, http://dx.doi.org/10.1158/0008-5472.CAN-08-4308
,2009, 'Quantitative real-time imaging of molecular dynamics during cancer cell invasion and metastasis in vivo', Cell Adhesion and Migration, 3, http://dx.doi.org/10.4161/cam.3.4.9460
,2009, 'Annexin A6 inhibits Ras signalling in breast cancer cells', Oncogene, 28, pp. 363 - 377, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18850003
,2009, 'The docking protein and proto-oncogene product Gab2 is regulated via a novel negative feedback mechanism mediated by 14-3-3 binding.', Cell communication and signaling : CCS, 7, pp. A12 - A12, http://dx.doi.org/10.1186/1478-811X-7-S1-A12
,2008, 'Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein', European Molecular Biology Organization, 27, pp. 2305 - 2316
,2008, 'Protein kinase C delta and calmodulin regulate epidermal growth factor receptor recycling from early endosomes through Arp2/3 complex and cortactin', Molecular Biology of the Cell, 19, pp. 17 - 29
,2007, 'Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib', Cancer research, 67, pp. 9304 - 9314
,2006, 'Src-dependent phosphorylation of Scar1 promotes its association with the Arp2/3 complex', Cell Motility and the Cytoskeleton, 63, pp. 6 - 13, http://dx.doi.org/10.1002/cm.20101
,2005, 'Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor', Cancer research, 65, pp. 3273 - 3280
,2005, 'Distinction at the leading edge of the cell', BioEssays, 27, pp. 349 - 352
,2004, 'A role for the actin cytoskeleton in cell death and aging in yeast', Journal of Cell Biology, 164, pp. 803 - 809, http://dx.doi.org/10.1083/jcb.200310148
,2001, 'Coordination of cell polarization and migration by the Rho family GTPases requires Src tyrosine kinase activity', Current Biology, 11, pp. 1836 - 1846, http://dx.doi.org/10.1016/S0960-9822(01)00583-8
,1997, 'Cryptosporidium parvum in environmental samples in the Sligo area, Republic of Ireland: A preliminary report', Letters in Applied Microbiology, 25, pp. 380 - 384, http://dx.doi.org/10.1046/j.1472-765X.1997.00248.x
,1996, 'Characterization of rainbow trout, Oncorhynchus mykiss (Walbaum), serum creatine kinase isoenzymes and isoforms by means of electrophoresis and isoelectric focusing', Journal of Fish Diseases, 19, pp. 441 - 447, http://dx.doi.org/10.1111/j.1365-2761.1996.tb00384.x
,Conference Papers
2023, 'The effect of adding a selective FAK inhibitor AMP945 to FOLFIRINOX in a model of pancreatic cancer.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2023 - 06 June 2023
,2019, 'ROBO2 is a stroma suppressor gene in the pancreas through regulation of TGF-beta', in CANCER IMMUNOLOGY RESEARCH, AMER ASSOC CANCER RESEARCH, http://dx.doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-A100
,2018, 'Unmixing spectrally overlapping FRET biosensors in vivo using multispectral FLIM (Conference Presentation)', in Periasamy A; So PT; Xie XS; König K (eds.), Multiphoton Microscopy in the Biomedical Sciences XVIII, SPIE, pp. 23 - 23, presented at Multiphoton Microscopy in the Biomedical Sciences XVIII, 27 January 2018 - 01 February 2018, http://dx.doi.org/10.1117/12.2290152
,2011, 'Abstract B147: P-Rex1 is required for efficient melanoma metastasis.', in Molecular Cancer Therapeutics, American Association for Cancer Research (AACR), pp. B147 - B147, http://dx.doi.org/10.1158/1535-7163.targ-11-b147
,2009, 'real-time study of E-cadherin dynamics in live animals using photo-activation and -bleaching', in CLINICAL & EXPERIMENTAL METASTASIS, SPRINGER, pp. 909 - 909, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000271722300190&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2001, 'Association of Scar with the Src tyrosine kinase consequences for Scar regulation', in BRITISH JOURNAL OF CANCER, CHURCHILL LIVINGSTONE, pp. 22 - 22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000170065300080&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Conference Posters
2013, 'From function genomics to precision medicine: the therapeutic potential of targeting rock signalling in pancreatic cancer', Chicago, IL, Vol. 9, pp. 53 - 53, presented at ASCO Annual Meeting, Chicago, IL, 31 May 2013 - 04 June 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000329462300024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Conference Presentations
2014, 'From functional genomics to precision medicine: Using well annotated models to define personalised treatment strategies for pancreatic cancer', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000341276000017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Conference Abstracts
2024, 'Identifying and targeting FOLFIRINOX resistance mechanisms to improve outcomes in pancreatic cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, MA, Boston, Vol. 84, presented at AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research, MA, Boston, 15 September 2024 - 18 September 2024, http://dx.doi.org/10.1158/1538-7445.PANCREATIC24-A067
,2024, 'Temporally resolved proteomics identifies nidogen-2 as a co-target in pancreatic cancer that modulates fibrosis and therapy response', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, MA, Boston, Vol. 84, presented at AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research, MA, Boston, 15 September 2024 - 18 September 2024, http://dx.doi.org/10.1158/1538-7445.PANCREATIC24-PR-09
,2024, 'Combining zelasudil, a small molecule ROCK2 inhibitor, with chemotherapy or immunotherapy improves response in preclinical models of pancreatic cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, Vol. 84, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2024 - 10 April 2024, http://dx.doi.org/10.1158/1538-7445.AM2024-720
,2024, 'Cyclin D1 induces Akt1 activity in RB deficient prostate cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, Vol. 84, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2024 - 10 April 2024, http://dx.doi.org/10.1158/1538-7445.AM2024-1634
,2024, '1354 The impact of the pancreatic tumour microenvironment on cytotoxic T lymphocyte migration and tumour eradication', in Regular and Young Investigator Award Abstracts, BMJ Publishing Group Ltd, pp. A1517 - A1517, presented at SITC 39th Annual Meeting (SITC 2024) Abstracts, http://dx.doi.org/10.1136/jitc-2024-sitc2024.1354
,2024, '1513P Impact of symptom and functional burden on survival in pancreatic ductal adenocarcinoma (PDAC)', in Annals of Oncology, Elsevier BV, Vol. 35, pp. S925 - S925, http://dx.doi.org/10.1016/j.annonc.2024.08.1576
,2023, 'Anti-fibrotic FAK 'priming' to improve contemporary chemotherapy in pancreatic cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, MA, Boston, Vol. 84, presented at AACR Special Conference - Pancreatic Cancer, MA, Boston, 27 September 2023 - 30 September 2023, http://dx.doi.org/10.1158/1538-7445.PANCA2023-B037
,